Tradestie Institutional Equity Comparison Engine
CGNX vs BMI โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CGNX Overall Edge
CGNX Captures Institutional Edge (3โ1 Pillars ยท 7โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cognex Corp (CGNX) driven by superior Valuation, Growth & Margin, Momentum & Technical while BMI counters with relative strength in Options & Structure. Fundamentally, CGNX trades at 24.7x Forward P/E with 25.0% operating margin (+13.2% YoY revenue) versus BMI at 31.0x Forward P/E and 18.8% operating margin (+0.1% YoY). In options structure, CGNX sits in BREAKDOWN (16th %ile IV; Dealer Gamma Walls on Pro) against BMI sits in SURGE (7th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
CGNX
CGNX 24.7x vs BMI 31.0x Fwd P/E
Growth & Margin Winner
CGNX
Op Margin 25.0% vs 18.8% ยท YoY +13.2% vs +0.1%
Momentum & Technical Winner
CGNX
1Y +29.7% vs -9.6% ยท 52W Pos 35% vs 65%
Options & Structure Winner
BMI
BREAKDOWN (16th %ile IV) vs SURGE (7th %ile IV)
CGNX
NASDAQ
Cognex Corp
Industrial Instruments For Measurement, Display, And Control
$48.06
-3.9% 1D
Market Cap
$8.5B
1M Return
-10.98%
1Y Return
+29.72%
Forward P/E
24.7x
Unified AI Score
59.5 / 100
HOLD
Tech 45.0
Fund 54.0
Flow 58.0
Mom 60.0
BMI
NYSE
Badger Meter, Inc.
Totalizing Fluid Meters & Counting Devices
$160.76
+3.9% 1D
Market Cap
$4.5B
1M Return
+27.1%
1Y Return
-9.58%
Forward P/E
31.0x
Unified AI Score
46.0 / 100
HOLD
Tech 32.0
Fund 47.0
Flow 56.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CGNX +29.72%
BMI -9.58%
Spread: +39.3 pp (CGNX Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CGNX Revenue | BMI Revenue | CGNX Op. Margin | BMI Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | $810M | $430M | 27.4% | 13.1% | CGNX |
| FY2019 | $730M | $420M | 19.7% | 14.6% | CGNX |
| FY2020 | $810M | $430M | 21.0% | 15.3% | CGNX |
| FY2021 | $1.04B | $510M | 30.4% | 15.6% | CGNX |
| FY2022 | $1.01B | $570M | 24.5% | 15.4% | CGNX |
| FY2023 | $840M | $700M | 15.6% | 16.8% | BMI |
| FY2024 | $910M | $830M | 12.6% | 19.1% | BMI |
| FY2025 | $990M | $920M | 16.3% | 20.0% | BMI |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CGNX | BMI | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $8.5B | $4.5B | Larger Scale | CGNX |
| Trailing P/E Ratio Valuation | 35.5x | 35.5x | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | 24.7x | 31.0x | Lower Multiple | CGNX |
| Revenue Growth (YoY) Growth | +13.2% | +0.1% | Higher Growth | CGNX |
| Operating Margin (TTM) Profitability | 25.0% | 18.8% | Higher Margin | CGNX |
| Net Profit Margin Profitability | 21.5% | 14.4% | Higher Margin | CGNX |
| Return on Equity (ROE) Capital Efficiency | 15.1% | 18.7% | Higher ROE | BMI |
| 52-Week Range Position Momentum | 35% ($35โ$73) | 65% ($112โ$187) | Stronger Trend | BMI |
| Beta / 30D Volatility Risk Regime | 2.19ฮฒ ยท 65% Vol | 0.49ฮฒ ยท 67% Vol | Lower Realized Risk | CGNX |
| Unified Institutional Score Composite Signal | 59.5 / 100 (HOLD) | 46.0 / 100 (HOLD) | Higher Composite | CGNX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CGNX vs BMI Buy Guide
CGNX
BREAKDOWN
120d in phase ยท OBV ACCUMULATION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
BMI
SURGE
7d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
7th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CGNX nor BMI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.